Innovation Pharmaceuticals Inc (IPIX)

[mantis]

Per share price for acquisitions makes no sense just by itself. You have to look at the total price. Gilead paid 11 billion for Pharmasset, which had 80 million shares. CTIX has 100 mil shares, which is comparable, but if Pharmasset had 10 million shares, 137 per share would have brought the total acquisition price to 1.37 bil and this would not have been a big transaction.